Elevated levels of CRP and MCP-1 measured early after a primary PCI treated STEMI in patients without previously known diabetes were associated with abnormal glucose regulation classified by an OGTT at three-month follow-up indicating an important role of low grade inflammation in glucose regulation. The gene discussed is CCL2; the disease is diabetes mellitus.